BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21074265)

  • 21. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation.
    Estellés A; Gilabert J; Keeton M; Eguchi Y; Aznar J; Grancha S; Espña F; Loskutoff DJ; Schleef RR
    Blood; 1994 Jul; 84(1):143-50. PubMed ID: 8018914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of modified lipoproteins on human trophoblast cells: a role in pre-eclampsia in pregnancies complicated by diabetes.
    McLeese RH; Zhao J; Fu D; Yu JY; Brazil DP; Lyons TJ
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33504507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
    Cheng M; He P; Fu J
    J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.
    Foidart JM; Schaaps JP; Chantraine F; Munaut C; Lorquet S
    J Reprod Immunol; 2009 Nov; 82(2):106-11. PubMed ID: 19853925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.
    Jena MK; Sharma NR; Petitt M; Maulik D; Nayak NR
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
    Luo X; Liu DD; Qi HB; Yao ZW
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory processes are specifically enhanced in endothelial cells by placental-derived TNF-α: Implications in preeclampsia (PE).
    Shaw J; Tang Z; Schneider H; Saljé K; Hansson SR; Guller S
    Placenta; 2016 Jul; 43():1-8. PubMed ID: 27324092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.
    Dias-Junior CA; Chen J; Cui N; Chiang CL; Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
    Biochem Pharmacol; 2017 Dec; 146():101-116. PubMed ID: 28912068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells.
    Li N; Fu Y; Chen W; Hu GQ; Zhou M; Yu SX; Zhang XJ; Du CT; Yang YJ
    J Hypertens; 2015 Aug; 33(8):1658-65. PubMed ID: 26002845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
    Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women with Preeclampsia.
    Weel IC; Baergen RN; Romão-Veiga M; Borges VT; Ribeiro VR; Witkin SS; Bannwart-Castro C; Peraçoli JC; De Oliveira L; Peraçoli MT
    PLoS One; 2016; 11(6):e0157584. PubMed ID: 27315098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
    Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
    Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placental Syncytiotrophoblast-Derived Extracellular Vesicles Carry Active NEP (Neprilysin) and Are Increased in Preeclampsia.
    Gill M; Motta-Mejia C; Kandzija N; Cooke W; Zhang W; Cerdeira AS; Bastie C; Redman C; Vatish M
    Hypertension; 2019 May; 73(5):1112-1119. PubMed ID: 30929513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia.
    Maynard SE; Venkatesha S; Thadhani R; Karumanchi SA
    Pediatr Res; 2005 May; 57(5 Pt 2):1R-7R. PubMed ID: 15817508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of soluble endoglin in BMP9 signaling.
    Lawera A; Tong Z; Thorikay M; Redgrave RE; Cai J; van Dinther M; Morrell NW; Afink GB; Charnock-Jones DS; Arthur HM; Ten Dijke P; Li W
    Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17800-17808. PubMed ID: 31431534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.